Valujskikh Anna, Fedoseyeva Eugenia, Benichou Gilles, Heeger Peter S
Department of Medicine and the Institute of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Transplantation. 2002 Apr 15;73(7):1130-7. doi: 10.1097/00007890-200204150-00021.
T cell allorecognition occurs through direct contact with donor peptide: MHC complexes on graft cells and through indirect recognition of donor-derived determinants expressed by recipient MHC molecules. As both indirect allorecognition and autoantigen recognition are self-restricted, we hypothesized that chronic activation of indirectly primed T cells might result in determinant spreading to involve autoantigens, analogous to that which occurs during chronic autoimmune diseases.
We placed C57BL/6 MHC II knockout (B6 II-/-) skin grafts onto BALB/c SCID mice reconstituted with wild-type (WT) CD4+ T cells. Under these conditions the CD4+ cells could not recognize any antigen on the graft, but could respond through the indirect pathway. CD4+ cell-mediated rejection of WT B6 skin was studied to determine if autoreactivity was induced after direct allorecognition. Recall immune responses against donor- and self-stimulator cells were determined by ELISPOT and animals were tested for their ability to reject second isografts.
WT allografts were rejected by day 14 although B6 II-/- grafts underwent delayed rejection over 4-5 weeks. CD4+ cells reisolated from the recipients of the MHC II-/- grafts, but not from the recipients of WT grafts, vigorously produced interferon-gamma and interleukin-2 in response to self, BALB/c stimulators. These autoreactive CD4+ T cells mediated rejection of a second isogenic BALB/c skin graft, demonstrating that the autoimmune response was pathogenic.
Autoreactivity can develop after transplant rejection via the indirect pathway. Although the direct alloresponse is likely to be the driving force in acute graft rejection, posttransplantation induced autoimmune responses may be important elements of delayed or chronic rejection.
T细胞同种异体识别通过与移植物细胞上的供体肽:MHC复合物直接接触以及通过间接识别受体MHC分子表达的供体来源决定簇来发生。由于间接同种异体识别和自身抗原识别均受自身限制,我们推测间接致敏T细胞的慢性激活可能导致决定簇扩展至涉及自身抗原,类似于慢性自身免疫性疾病中发生的情况。
我们将C57BL/6 MHC II基因敲除(B6 II-/-)皮肤移植物移植到用野生型(WT)CD4+ T细胞重建的BALB/c SCID小鼠上。在这些条件下,CD4+细胞无法识别移植物上的任何抗原,但可通过间接途径作出反应。研究了CD4+细胞介导的WT B6皮肤排斥反应,以确定直接同种异体识别后是否诱导了自身反应性。通过ELISPOT测定针对供体和自身刺激细胞的回忆免疫反应,并测试动物排斥第二次同基因移植物的能力。
WT同种异体移植物在第14天被排斥,尽管B6 II-/-移植物在4 - 5周内出现延迟排斥。从MHC II-/-移植物受体中重新分离的CD4+细胞,而非WT移植物受体中的CD4+细胞,在受到自身、BALB/c刺激物刺激时能强烈产生干扰素-γ和白细胞介素-2。这些自身反应性CD4+ T细胞介导了第二次同基因BALB/c皮肤移植物的排斥,表明自身免疫反应具有致病性。
移植排斥后可通过间接途径产生自身反应性。尽管直接同种异体反应可能是急性移植物排斥的驱动力,但移植后诱导的自身免疫反应可能是延迟或慢性排斥的重要因素。